Industries > Pharma > Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

Branded Drugs, Generic Drugs, Leading Companies

PUBLISHED: 03 October 2018
PAGES: 229
PRODUCT CODE: PHA0335
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0335 Categories: , Tags: , , ,

The pharmaceutical wholesale and distribution market is vital, providing access to life saving drugs to vast number of people in a timely manner. The market is large, with many opportunities for growth and development during the forecast period.

The establishment of the pharmaceutical wholesale market was driven by manufacturers wanting to outsource distribution to wholesalers to focus on core competencies of R&D and marketing. At the same time, hospitals outsourced inventory management in an effort to reduce investment in this area. These factors created a high demand for a comprehensive wholesale and distribution service.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 229-page report you will receive 132 charts– all unavailable elsewhere.

The 229-page report provides clear detailed insight into the leading pharmaceutical wholesale & distribution organizations. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical Wholesale & Distribution Market Size in 2017 and forecasts to 2027

• Global Pharmaceutical Wholesale & Distribution Market Size in 2017 and forecasts to 2027 segmented by submarket:
• Branded Drugs
• Generic Drugs
• Others

• A SWOT and STEP analysis of the global pharmaceutical wholesale & distribution market

• Profiles of the 20 leading pharmaceutical wholesale & distribution organizations:
• Alfresa Holdings
• AmerisourceBergen
• Anda Inc.
• Cardinal Health
• CR Pharmaceutical
• CuraScript Special
• Fortissa Limited
• H.D. Smith
• Mawdsley-Brooks & Co. Ltd.
• McKesson
• MEDIPAL HOLDINGS
• Morris & Dickson Co. LLC
• North Carolina Mutual Wholesale Drug
• Prodigy Health
• Shanghai Pharmaceutical Holdings.
• SINOPHARM
• Smith Drug Company
• SUZUKEN
• The PHOENIX Group
• Walgreens Boots AllianceSUZUKEN
• The PHOENIX Group
• Walgreens Boots Alliance

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

• The content of each profile differs, depending on the organization. In general, a profile gives the following information:
• Overview of the company’s services and operations
• Analysis of recent financial performance – annual revenue for services, including data on operating profit and margins
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations

Visiongain’s study is intended for anyone requiring commercial analyses for pharmaceutical wholesale & distribution market. You find data, trends and predictions.

Buy our report today Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018: Branded Drugs, Generic Drugs, Leading Companies

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018


Download sample pages

Complete the form below to download your free sample pages for Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category